av/merrimack-pharmaceuticals--big.svg

NASDAQ:MACK

Merrimack Pharmaceuticals, Inc.

  • Stock

USD

Last Close

15.10

14/05 20:00

Market Cap

189.75M

Beta: 1.80

Volume Today

1.68M

Avg: 70.31K

PE Ratio

−152.04

PFCF: −135.35

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.25
-
0.65
160.79%
0.38
41.33%
1.77
365.93%
-0.02
-
cash conversion cycle
-10.54K
-
634.05
106.01%
cash per share
15.69
-
11.88
24.29%
16.67
40.31%
1.72
89.70%
7.06
311.19%
5.34
24.35%
1.24
76.76%
1.05
15.50%
1.06
0.97%
1.44
35.68%
1.32
8.16%
company equity multiplier
-4.43
-
-1.55
64.91%
-1.28
17.79%
-0.32
74.59%
1.22
475.54%
1.51
23.54%
1.16
22.94%
1.05
9.65%
1.04
0.81%
1.03
0.87%
1.02
0.69%
days of inventory outstanding
29.49K
-
768.55
97.39%
days of payables outstanding
40.06K
-
178.70
99.55%
days of sales outstanding
44.74
-
11.77
73.69%
26.51
125.28%
44.20
66.71%
dividend yield
0.00
-
0.00
4.28%
1.31
-
0.63
-
ebit per revenue
-2.52
-
-0.64
74.44%
-1.45
125.13%
-0.76
47.41%
3.89
-
ebt per ebit
1.08
-
1.26
16.33%
1.14
9.56%
1.39
22.20%
1.24
11.30%
1.04
15.56%
1.02
2.58%
1.05
3.15%
0.99
5.45%
0.89
10.15%
0.54
39.72%
effective tax rate
0.02
-
0.04
132.43%
0.03
36.54%
0.09
224.92%
0.36
315.71%
0.11
68.61%
0.06
42.37%
-0.00
107.17%
-0.00
73.66%
-0.00
59.12%
-0.01
427.29%
enterprise value multiple
-3.83
-
-15.29
299.29%
-5.91
61.35%
-6.07
2.78%
-0.15
97.61%
-0.56
284.36%
-1.07
91.33%
-15.17
1,322.09%
-13.85
8.70%
-51.75
273.76%
-85.37
64.95%
fixed asset turnover
3.58
-
7.09
98.16%
4.07
42.52%
9.15
124.69%
free cash flow per share
-10.62
-
-3.91
63.16%
-10.61
171.22%
-13.84
30.40%
-11.10
19.78%
-4.92
55.63%
-2.35
52.30%
-0.35
85.29%
-0.02
95.30%
-0.13
692.17%
-0.11
17.36%
gross profit margin
1
-
1
0%
1.00
0.05%
0.95
4.74%
1
-
interest coverage
-11.02
-
-3.63
67.02%
-6.74
85.37%
-2.52
62.54%
-2.76
9.52%
-68.59
2,381.83%
-14.63
78.67%
9.20
-
inventory turnover
0.01
-
0.47
3,737.57%
long term debt to capitalization
1.72
-
22.89
1,227.07%
3.49
84.73%
-6.33
281.13%
0.20
-
net income per ebt
1.00
-
1.00
0.50%
1.00
0.44%
0.99
1.27%
-3.99
503.33%
0.59
114.84%
0.94
58.07%
1.00
7.42%
1.00
0.34%
1.00
0.07%
1.01
0.83%
net profit margin
-2.74
-
-0.81
70.42%
-1.66
104.50%
-1.05
36.55%
3.47
-
operating cash flow per share
-9.62
-
-3.33
65.35%
-9.46
183.80%
-13.58
43.57%
-11.03
18.81%
-4.92
55.43%
-2.35
52.21%
-0.35
85.29%
-0.02
95.30%
-0.13
692.17%
-0.11
17.36%
operating cycle
29.52K
-
812.74
97.25%
operating profit margin
-2.52
-
-0.64
74.44%
-1.45
125.13%
-0.76
47.41%
3.89
-
payables turnover
0.01
-
2.04
22,319.24%
pretax profit margin
-2.73
-
-0.81
70.27%
-1.66
103.61%
-1.06
35.73%
3.46
-
price fair value
-9.54
-
-9.09
4.78%
-3.76
58.59%
-1.60
57.43%
1.11
169.14%
0.69
37.74%
2.43
252.32%
5.76
137.06%
3.70
35.85%
8.05
117.93%
10.23
27.02%
receivables turnover
8.16
-
31.02
280.15%
13.77
55.61%
8.26
40.01%
return on assets
-0.68
-
-0.52
22.85%
-0.63
19.99%
-1.86
195.63%
4.02
316.04%
-0.46
111.37%
-1.06
131.49%
-0.18
82.96%
-0.17
7.78%
-0.08
53.24%
-0.06
20.93%
return on capital employed
-0.89
-
-1.39
55.81%
-0.99
29.14%
16.34
1,754.10%
-0.98
106.01%
-0.89
9.43%
-1.29
45.25%
-0.18
86.10%
-0.17
2.93%
-0.09
48.44%
-0.12
29.21%
return on equity
3.01
-
0.82
72.93%
0.80
1.35%
0.60
24.88%
4.90
711.33%
-0.69
114.05%
-1.23
78.38%
-0.19
84.60%
-0.17
8.53%
-0.08
53.64%
-0.06
21.47%
total debt to capitalization
1.64
-
6.67
307.44%
3.49
47.61%
20.54
487.64%
0.20
-

All numbers in USD (except ratios and percentages)